The KIR genes and their HLA class I ligands have thus far not been investigated in pemphigus foliaceus (PF) and related autoimmune diseases, such as pemphigus vulgaris. We genotyped 233 patients and 204 controls for KIR by PCR-SSP. HLA typing was performed by LABType SSO reagent kits. We estimated the odds ratio, 95% confidence interval and performed logistic regression analyses to test the hypothesis that KIR genes and their known ligands influence susceptibility to PF. We found significant negative association between activating genes and PF. The activating KIR genes may have an overlapping effect in the PF susceptibility and the presence of more than three activating genes was protective (OR = 0.49, p = 0.003). A strong protective association was found for higher ratios activating/inhibitory KIR (OR = 0.44, p = 0.001). KIR3DS1 and HLA-Bw4 were negatively associated to PF either isolated or combined, but higher significance was found for the presence of both together (OR = 0.34, p<10？3) suggesting that the activating function is the major factor to interfere in the PF pathogenesis. HLA-Bw4 (80I and 80T) was decreased in patients. There is evidence that HLA-Bw4(80T) may also be important as KIR3DS1 ligand, being the association of this pair (OR = 0.07, p = 0.001) stronger than KIR3DS1-Bw4(80I) (OR = 0.31, p = 0.002). Higher levels of activating KIR signals appeared protective to PF. The activating KIR genes have been commonly reported to increase the risk for autoimmunity, but particularities of endemic PF, like the well documented influence the environmental exposure in the pathogenesis of this disease, may be the reason why activated NK cells probably protect against pemphigus foliaceus.
References
[1]
Chidgey M (2002) Desmosomes and disease: an update. Histol Histopathol 17: 1179–1192.
[2]
Sampaio SA, Rivitti EA, Aoki V, Diaz LA (1994) Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire). Dermatol Clin 12: 765–776.
[3]
Hans-Filho G, dos Santos V, Katayama JH, Aoki V, Rivitti EA, et al. (1996) An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research. J Invest Dermatol 107: 68–75.
Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, et al. (2001) Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167: 5439–5448.
[6]
Petzl-Erler ML, Santamaria J (1989) Are HLA class II genes controlling susceptibility and resistance to Brazilian pemphigus foliaceus (fogo selvagem)? Tissue Antigens 33: 408–414.
[7]
Pavoni DP, Roxo VM, Marquart Filho A, Petzl-Erler ML (2003) Dissecting the associations of endemic pemphigus foliaceus (Fogo Selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun 4: 110–116.
[8]
Pereira NF, Hansen JA, Lin MT, Roxo VM, Braun K, et al. (2004) Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants. Cytokine 28: 233–241.
[9]
Petzl-Erler ML, Malheiros D (2005) Pemphigus foliaceus and desmoglein 1 gene polymorphism: is there any relationship? J Autoimmun 25: 121–125.
[10]
Pincerati MR, Dalla-Costa R, Petzl-Erler ML (2010) CTLA4CT60 gene polymorphism is not associated with differential susceptibility to pemphigus foliaceus. Genet Mol Biol 33: 442–444.
[11]
Pavoni DP, Cerqueira LB, Roxo VM, Petzl-Erler ML (2006) Polymorphism of the promoter region and exon 1 of the CTLA4 gene in endemic pemphigus foliaceus (fogo selvagem). Braz J Med Biol Res 39: 1227–1232.
[12]
Malheiros D, Petzl-Erler ML (2009) Individual and epistatic effects of genetic polymorphisms of B-cell co-stimulatory molecules on susceptibility to pemphigus foliaceus. Genes Immun 10: 547–558.
[13]
Parham P (2005) Immunogenetics of killer cell immunoglobulin-like receptors. Mol Immunol 42: 459–462.
[14]
Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161: 571–577.
[15]
Foley B, De Santis D, Lathbury L, Christiansen F, Witt C (2008) KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 20: 555–563.
[16]
Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P (2010) Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J Immunol 185: 4233–4237.
[17]
Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, et al. (2007) Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178: 33–37.
[18]
Carr WH, Pando MJ, Parham P (2005) KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175: 5222–5229.
[19]
Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M (1994) NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180: 1235–1242.
[20]
Augusto DG, Zehnder-Alves L, Pincerati MR, Martin MP, Carrington M, et al. (2012) Diversity of the KIR gene cluster in an urban Brazilian population. Immunogenetics 64: 143–152.
[21]
Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027–3036.
[22]
von Bubnoff D, Andres E, Hentges F, Bieber T, Michel T, et al. (2010) Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 125: 60–68.
[23]
Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, et al. (2007) T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol 127: 324–330.
[24]
Stern JN, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, et al. (2008) Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. Clin Exp Immunol 152: 472–481.
[25]
Kulkarni S, Martin MP, Carrington M (2008) The Yin and Yang of HLA and KIR in human disease. Semin Immunol 20: 343–352.
[26]
Uhrberg M, Parham P, Wernet P (2002) Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54: 221–229.
[27]
Yusa S, Catina TL, Campbell KS (2002) SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol 168: 5047–5057.
[28]
Faure M, Long EO (2002) KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 168: 6208–6214.
[29]
Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS (2003) KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171: 3415–3425.
[30]
Trundley AE, Hiby SE, Chang C, Sharkey AM, Santourlidis S, et al. (2006) Molecular characterization of KIR3DL3. Immunogenetics 57: 904–916.
[31]
Hsu KC, Liu XR, Selvakumar A, Mickelson E, O’Reilly RJ, et al. (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169: 5118–5129.
[32]
Parham P (2004) Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol Lett 92: 11–13.
[33]
van der Slik AR, Alizadeh BZ, Koeleman BP, Roep BO, Giphart MJ (2007) Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue Antigens 69: 101–105.
[34]
Shi FD, Wang HB, Li H, Hong S, Taniguchi M, et al. (2000) Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1: 245–251.
[35]
Eaton DP, Diaz LA, Hans-Filho G, Santos VD, Aoki V, et al. (1998) Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the State of Mato Grosso do Sul, Brazil. The Cooperative Group on Fogo Selvagem Research. J Med Entomol 35: 120–131.
[36]
Schleinitz N, Vely F, Harle JR, Vivier E (2010) Natural killer cells in human autoimmune diseases. Immunology 131: 451–458.
[37]
Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, et al. (1997) Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 158: 5237–5241.
[38]
Braun-Prado K, Vieira Mion AL, Farah Pereira N, Culpi L, Petzl-Erler ML (2000) HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population. Tissue Antigens 56: 417–427.
[39]
Probst CM, Bompeixe EP, Pereira NF, de ODMM, Visentainer JE, et al. (2000) HLA polymorphism and evaluation of European, African, and Amerindian contribution to the white and mulatto populations from Parana, Brazil. Hum Biol 72: 597–617.
[40]
Kulkarni S, Martin MP, Carrington M (2010) KIR genotyping by multiplex PCR-SSP. Methods Mol Biol 612: 365–375.
[41]
Vilches C, Castano J, Gomez-Lozano N, Estefania E (2007) Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70: 415–422.
[42]
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748.
[43]
Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform 1: 47–50.
[44]
Kimoto Y, Horiuchi T, Tsukamoto H, Kiyohara C, Mitoma H, et al. (2010) Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections. Rheumatology (Oxford) 49: 1346–1353.
[45]
Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, et al. (2007) KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 69: 106–108.
[46]
Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, et al. (2011) KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet 38: 403–409.
[47]
Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, et al. (2008) Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 28: 343–349.
Williams F, Meenagh A, Sleator C, Cook D, Fernandez-Vina M, et al. (2005) Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 66: 836–841.
[50]
Martin MP, Nelson G, Lee JH, Pellett F, Gao X, et al. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169: 2818–2822.
[51]
Nikitina-Zake L, Rajalingham R, Rumba I, Sanjeevi CB (2004) Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann N Y Acad Sci 1037: 161–169.
[52]
Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, et al. (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193: 1159–1167.
[53]
Luszczek W, Manczak M, Cislo M, Nockowski P, Wisniewski A, et al. (2004) Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65: 758–766.
[54]
Suzuki Y, Hamamoto Y, Ogasawara Y, Ishikawa K, Yoshikawa Y, et al. (2004) Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 122: 1133–1136.
[55]
Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, et al. (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46: 899–906.
